MoneyWorks4Me

Morepen Laboratories - Quaterly Results

05 May 2022 Evaluate
The sales figure stood at Rs. 3424.42 millions for the March 2022 quarter. The mentioned figure indicates a growth of about 29.66% as compared to Rs. 2641.05 millions during the year-ago period.Profit after Tax for the quarter ended March 2022 saw a decline of -43.23% from Rs. 251.44 millions to Rs. 142.75  millions.The Operating Profit of the company witnessed a decrease to 222.87 millions from 315.21 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 3424.42 2641.05 29.66 14492.67 11124.23 30.28 14492.67 11124.23 30.28
Other Income 31.08 38.68 -19.65 102.35 117.74 -13.07 102.35 117.74 -13.07
PBIDT 222.87 315.21 -29.29 1393.72 1241.47 12.26 1393.72 1241.47 12.26
Interest 7.96 -0.54 -1574.07 -73.66 17.88 -511.97 -73.66 17.88 -511.97
PBDT 214.91 315.75 -31.94 1467.38 1223.59 19.92 1467.38 1223.59 19.92
Depreciation 48.20 64.31 -25.05 211.95 281.10 -24.60 211.95 281.10 -24.60
PBT 166.71 251.44 -33.70 1255.43 942.49 33.20 1255.43 942.49 33.20
TAX 23.96 0.00 0.00 244.81 0.00 0.00 244.81 0.00 0.00
Deferred Tax 24.83 0.00 0.00 24.83 0.00 0.00 24.83 0.00 0.00
PAT 142.75 251.44 -43.23 1010.62 942.49 7.23 1010.62 942.49 7.23
Equity 955.59 899.59 6.23 955.59 899.59 6.23 955.59 899.59 6.23
PBIDTM(%) 6.51 11.94 -45.47 9.62 11.16 -13.83 9.62 11.16 -13.83
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..